RUBILIM

This brand name is authorized in South Africa

Active ingredients

The drug RUBILIM contains one active pharmaceutical ingredient (API):

1 Valproic acid UNII 5VOM6GYJ0D - VALPROATE SODIUM

Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA. Read about Valproic acid

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RUBILIM Prolonged release tablet	Health Products Regulatory Authority (ZA)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N03AG01	Valproic acid	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ZA	Health Products Regulatory Authority	Identifier(s): 55/2.5/0538, 55/2.5/0539, 55/2.5/0540